18 December 2020 Biologics Spondyloarthritis Gilead will not pursue FDA approval of filgonitib for RA
27 August 2020 Analgesics Axial spondyloarthritis Conditions Spondyloarthritis Filgotinib on hold: FDA delays decision to approve JAKi for RA